SHR-1701 in Combination With Stereotactic Body Radiotherapy in mCRPC

Clinical trial NCT07451795 · RECRUITING

Trial details

NCT number: NCT07451795
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer mCRPC (Metastatic Castration-resistant Prostate Cancer)

Start date: 2026-03-02
Primary completion: 2028-03-31
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.